Passage BIO, Inc.·4

Feb 18, 7:33 PM ET

Morris Richard Steven 4

4 · Passage BIO, Inc. · Filed Feb 18, 2021

Insider Transaction Report

Form 4
Period: 2021-02-16
Morris Richard Steven
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-16+50,00050,000 total
    Exercise: $21.85Exp: 2031-02-15Common Stock (50,000 underlying)
Holdings
  • Common Stock

    1,788
Footnotes (2)
  • [F1]Reflects 2020 Employee Stock Purchase Plan allocations of 1,388 shares that occurred since the date of the reporting person's last ownership report.
  • [F2]The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION